Target Healthcare REIT (LON:THRL) Hits New 52-Week High – Still a Buy?

Posted by Teresa Graham on May 15th, 2026

Target Healthcare REIT (LON:THRL – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as GBX 110 and last traded at GBX 106.36, with a volume of 1300578 shares changing hands. The stock had previously closed at GBX 107.60.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reissued a “hold” rating and issued a GBX 101 price target on shares of Target Healthcare REIT in a report on Wednesday, May 6th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, Target Healthcare REIT currently has an average rating of “Hold” and an average price target of GBX 101.

Read Our Latest Stock Analysis on Target Healthcare REIT

Target Healthcare REIT Trading Down 1.7%

The business’s fifty day simple moving average is GBX 103.43 and its two-hundred day simple moving average is GBX 101.01. The stock has a market capitalization of £643.81 million, a P/E ratio of 8.26, a P/E/G ratio of 1.48 and a beta of 0.69.

Target Healthcare REIT (LON:THRL – Get Free Report) last issued its quarterly earnings results on Wednesday, March 18th. The company reported GBX 3.38 earnings per share for the quarter. Target Healthcare REIT had a net margin of 104.45% and a return on equity of 10.73%. On average, equities research analysts anticipate that Target Healthcare REIT will post 6.2219101 earnings per share for the current year.

Target Healthcare REIT Company Profile

(Get Free Report)

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.